Skip to main content

Jefferies Financial Group Inc.

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 96223 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$0
+$0 QoQ
Shares Held
219,000
+2412.0% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
23,400
PutValue
$0
PutShares
700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
37 filing rows on record
Report Date Value (USD) Shares
2026-03-31 219,000
2025-12-31 23,400
2025-12-31 700
2025-12-31 8,718
2025-09-30 251,555
2025-09-30 700
2025-09-30 23,400
2025-06-30 700
2025-06-30 23,400
2025-06-30 578,205
2025-03-31 23,400
2025-03-31 700
2025-03-31 599,255
2024-12-31 341,361
2024-12-31 57,000
2024-12-31 700
2024-09-30 48,511
2024-09-30 57,000
2024-09-30 10,200
2024-06-30 57,000
2024-06-30 636
2024-06-30 10,200
2024-03-31 636
2024-03-31 57,000
2024-03-31 10,200
2023-12-31 2,000
2023-12-31 3,200
2023-12-31 22,544
2023-09-30 100
2023-09-30 4,308
2023-09-30 2,000
2023-06-30 17,200
2023-06-30 132,000
2023-06-30 41,200
2023-03-31 16,500
2023-03-31 2,475
2023-03-31 130,000